These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36291610)

  • 41. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines by proteome analysis.
    Meng Q; Lei T; Zhang M; Zhao J; Zhao XH; Zhang M
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):509-19. PubMed ID: 23183654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells.
    Gao Z; Gao Z; Fields JZ; Boman BM
    Anticancer Res; 1998; 18(4C):3073-6. PubMed ID: 9713512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray.
    Liu Y; Peng H; Zhang JT
    Mol Pharmacol; 2005 Aug; 68(2):430-8. PubMed ID: 15901850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer.
    Lo YW; Lin ST; Chang SJ; Chan CH; Lyu KW; Chang JF; May EW; Lin DY; Chou HC; Chan HL
    J Cell Mol Med; 2015 Apr; 19(4):744-59. PubMed ID: 25639359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells.
    Singhal SS; Singhal J; Sharma R; Singh SV; Zimniak P; Awasthi YC; Awasthi S
    Int J Oncol; 2003 Feb; 22(2):365-75. PubMed ID: 12527936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of ATP-Binding Cassette Transporter Proteins in CNS Tumors: Resistance- Based Perspectives and Clinical Updates.
    Asif M; Usman M; Ayub S; Farhat S; Huma Z; Ahmed J; Kamal MA; Hussein D; Javed A; Khan I
    Curr Pharm Des; 2020; 26(37):4747-4763. PubMed ID: 32091329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
    Giaccone G; van Ark-Otte J; Rubio GJ; Gazdar AF; Broxterman HJ; Dingemans AM; Flens MJ; Scheper RJ; Pinedo HM
    Int J Cancer; 1996 Jun; 66(6):760-7. PubMed ID: 8647646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
    Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
    Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model.
    Funazo T; Tsuji T; Ozasa H; Furugaki K; Yoshimura Y; Oguri T; Ajimizu H; Yasuda Y; Nomizo T; Sakamori Y; Yoshida H; Kim YH; Hirai T
    Mol Cancer Ther; 2020 Jun; 19(6):1320-1327. PubMed ID: 32217741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells.
    Sinha BK; Perera L; Cannon RE
    Biomed Pharmacother; 2019 Dec; 120():109468. PubMed ID: 31605952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Revisiting the role of ABC transporters in multidrug-resistant cancer.
    Robey RW; Pluchino KM; Hall MD; Fojo AT; Bates SE; Gottesman MM
    Nat Rev Cancer; 2018 Jul; 18(7):452-464. PubMed ID: 29643473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters.
    Schneiderman RS; Shmueli E; Kirson ED; Palti Y
    BMC Cancer; 2010 May; 10():229. PubMed ID: 20492723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
    Nakamura Y; Oka M; Soda H; Shiozawa K; Yoshikawa M; Itoh A; Ikegami Y; Tsurutani J; Nakatomi K; Kitazaki T; Doi S; Yoshida H; Kohno S
    Cancer Res; 2005 Feb; 65(4):1541-6. PubMed ID: 15735043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2.
    Hosokawa Y; Takahashi H; Inoue A; Kawabe Y; Funahashi Y; Kameda K; Sugimoto K; Yano H; Harada H; Kohno S; Ohue S; Ohnishi T; Tanaka J
    Biochim Biophys Acta; 2015 Jun; 1850(6):1197-205. PubMed ID: 25644290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.
    Clynes M; Redmond A; Moran E; Gilvarry U
    Cytotechnology; 1992; 10(1):75-89. PubMed ID: 1369413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Modeling Strategies of Cancer Multidrug Resistance.
    Yalcin-Ozkat G
    Drug Resist Updat; 2021 Dec; 59():100789. PubMed ID: 34973929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
    Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
    Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
    Heffeter P; Jakupec MA; Körner W; Chiba P; Pirker C; Dornetshuber R; Elbling L; Sutterlüty H; Micksche M; Keppler BK; Berger W
    Biochem Pharmacol; 2007 Jun; 73(12):1873-86. PubMed ID: 17445775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.